Temporomandibular Joint Disorders During HIV Infection: A Case Report

Temporomandibular disorders (TMD) is a term reflecting chronic, painful, craniofacial conditions usually of unclear etiology with impaired jaw function. Human immunodeficiency virus (HIV)- infected patients often report chronic pain and pathologies targeting body joints during retroviral therapy. Although both conditions may share similar secondary disorders, no conclusive cause-effect relationship has been found linking the TMD to the HIV-antiviral treatment. This report describes a case of TMD associated with HIV infection during active retroviral therapy. Clinicians should be aware that treatment of an HIV-infected patient with TMD requires an interdisciplinary team approach.

human immunodeficiency virus; infection, pain; retroviral therapy; temporomandibular disorders; temporomandibular joint

1. Okeson JO. Differential diagnosis and management considerations of temporomandibular disorders. In: Okeson JP (ed). Orofacial Pain: Guidelines for Assessment, Diagnosis, and Management. Chicago: Quintessence, 1996:113–158.

2. Paesani D, Westesson P-L, Hatala M, Tallents RH, Kurita

K. Prevalence of temporomandibular joint internal derangement in patients with craniomandibular disorders. Am J Orthod Dentofac Orthop 1992;101:41–47.

3. Kulthanan K, Jiamton S, Omcharoen V, Linpiyawan R, Ruangpeerakul J, Sivayathorn A. Autoimmune and rheumatic manifestations and antinuclear antibody study in HIV-infected Thai patients. Int J Dermatol 2002;41: 417–422.

4. Tsao JC, Stein JA, Dobalian A. Pain, problem drug use history, and aberrant analgesic use behaviors in persons living with HIV. Pain 2007;133:128–137.

5. Anheim M, Echaniz-Laguna A, Rey D, Tranchant C. Pure trigeminal motor neuropathy presenting with temporomandibular joint dysfunction in a patient with HIV and HCV infections. Rev Neurol 2006;162:92–94.

6. Florence E, Schrooten W, Verdonck K, Dreezen C, Colebunders R. Rheumatological complications associated with the use of indinavir and other protease inhibitors. Ann Rheum Dis 2002;61:82–84.

7. Coplan PM, Cook JR, Carides GW, et al. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine. Clin Infect Dis 2004;39:426–433.

8. Muñoz Fernandez S, Cardenal A, Balsa A, et al. Rheumatic manifestations in 556 patients with human immuno-deficiency virus infection. Semin Arthritis Rheum 1991;21: 30–39.

9. Grasland A, Ziza JM, Raguin G, Pouchot J, Vinceneux P. Adhesive capsulitis of shoulder and treatment with protease inhibitors in patients with HIV infection: Report of 8 cases. J Rheumatol 2000;27:2642–2646.

10. Leone J, Benguinat I, Dehlinger V, et al. Adhesive capsulitis of the shoulder induced by protease inhibitor therapy. Three new cases. Rev Rhum Engl Ed 1998;65:800–801.

11. Brooks JI, Gallicano K, Garber G, Angel JB. Acute monoarthritis complicating therapy with indinavir. AIDS 2000; 14:2064–2065.

12. Korszun A, Hinderstein B, Wong M. Comorbidity of depression with chronic facial pain and temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:496–500.

13. De Leeuw R, Klasser GD, Albuquerque RJC. Are female patients with orofacial pain medically compromised? JADA 2005;136:459–468.

14. Douaihy AB, Stowell KR, Kohnen S, Stoklosa JB, Breitbart WS. Psychiatric aspects of comorbid HIV/AIDS and pain, Part 1. AIDS Read 2007;17:310–314.

15. Verma A, Bradley WG. HIV-1-associated neuropathies. CNS Spectr 2000;5:66–72.

16. Katsarava Z, Yaldizli O, Voulkoudis C, Diener HC, Kaube H, Maschke M. Pain related potentials by electrical stimulation of skin for detection of small-fiber neuropathy in HIV. J Neurol 2006;253:1581–1584.

17. Lund JP, Sessle BJ. Neurophysiological mechanisms. In: Zarb GA, Carlsson GE, Sessle BJ, Mohl ND (eds). Temporomandibular Joint and Masticatory Muscle Disorders. Munksgard-Copenhagen: Mosby, 1994:188–207.

18. De Ponti A, Vigano MG, Taverna E, Sansone V. Adhesive capsulitis of the shoulder in HIV-positive patients during highly active antiretroviral therapy. J Shoulder Elbow Surg 2006;15:188–190.

19. Diwan DB, Murrell GA. An evaluation of the effects of the extent of capsular release and of postoperative therapy on the temporal outcomes of adhesive capsulitis. Arthroscopy 2005;21:1105–1113.

20. Kaneyama K, Segami N, Sato J, Murakami K, Iizuka T. Outcomes of 152 temporomandibular joints following arthroscopic anterolateral capsular release by holmium: YAG laser or electrocautery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:546–551.